A detailed history of Franklin Resources Inc transactions in Dexcom Inc stock. As of the latest transaction made, Franklin Resources Inc holds 2,176,020 shares of DXCM stock, worth $164 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,176,020
Previous 4,017,403 45.84%
Holding current value
$164 Million
Previous $455 Million 67.98%
% of portfolio
0.04%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $118 Million - $214 Million
-1,841,383 Reduced 45.84%
2,176,020 $146 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.8 Million - $2.29 Million
16,281 Added 0.41%
4,017,403 $455 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $231 Million - $283 Million
2,019,885 Added 101.95%
4,001,122 $555 Million
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $52.9 Million - $87.1 Million
701,339 Added 54.8%
1,981,237 $246 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $2.92 Million - $4.69 Million
33,970 Added 2.73%
1,279,898 $119 Million
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $8.05 Million - $9.37 Million
71,549 Added 6.09%
1,245,928 $160 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $4.28 Million - $5.06 Million
41,132 Added 3.63%
1,174,379 $136 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $21.6 Million - $31.2 Million
254,674 Added 28.99%
1,133,247 $128 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $36.8 Million - $45.4 Million
-482,312 Reduced 35.44%
878,573 $70.8 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $62.8 Million - $123 Million
923,239 Added 210.96%
1,360,885 $101 Million
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $7.86 Million - $10.9 Million
83,553 Added 23.6%
437,646 $224 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $11.8 Million - $14.8 Million
90,778 Added 34.48%
354,093 $190 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $4.81 Million - $6.46 Million
45,086 Added 20.66%
263,315 $144 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $580,293 - $773,318
7,165 Added 3.39%
218,229 $93.2 Million
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $10.3 Million - $12.7 Million
-121,502 Reduced 36.53%
211,064 $75.9 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $200,460 - $268,565
2,570 Added 0.78%
332,566 $123 Million
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $4.75 Million - $5.62 Million
-49,769 Reduced 13.11%
329,996 $136 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $7.68 Million - $12.9 Million
122,492 Added 47.61%
379,765 $162 Million
Q1 2020

May 13, 2020

SELL
$47.79 - $75.63 $2.14 Million - $3.38 Million
-44,728 Reduced 14.81%
257,273 $69.3 Million
Q4 2019

Feb 12, 2020

BUY
$36.62 - $57.29 $1.19 Million - $1.85 Million
32,377 Added 12.01%
302,001 $66.1 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $77,810 - $95,922
2,190 Added 0.82%
269,624 $40.2 Million
Q2 2019

Aug 14, 2019

BUY
$27.84 - $38.92 $1 Million - $1.4 Million
36,028 Added 15.57%
267,434 $40.1 Million
Q1 2019

May 14, 2019

SELL
$28.07 - $38.18 $2.77 Million - $3.77 Million
-98,805 Reduced 29.92%
231,406 $27.6 Million
Q4 2018

Feb 12, 2019

SELL
$26.99 - $37.37 $3.06 Million - $4.23 Million
-113,312 Reduced 25.55%
330,211 $39.6 Million
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $9.2 Million - $14.5 Million
-393,845 Reduced 47.03%
443,523 $63.4 Million
Q2 2018

Aug 14, 2018

SELL
$17.54 - $25.22 $5.82 Million - $8.37 Million
-331,698 Reduced 28.37%
837,368 $79.5 Million
Q1 2018

May 10, 2018

BUY
$13.06 - $18.54 $41,569 - $59,012
3,183 Added 0.27%
1,169,066 $86.7 Million
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $162,752 - $225,101
-14,636 Reduced 1.24%
1,165,883 $66.9 Million
Q3 2017

Nov 13, 2017

BUY
$11.36 - $18.98 $13.4 Million - $22.4 Million
1,180,519
1,180,519 $57.8 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.